Canada markets closed

Codexis, Inc. (CDXS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.6100-0.1600 (-4.24%)
At close: 04:00PM EDT
3.6000 -0.01 (-0.28%)
After hours: 07:23PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close3.7700
Open3.7700
Bid3.5900 x 300
Ask3.6400 x 300
Day's Range3.5800 - 3.7700
52 Week Range1.4500 - 4.9100
Volume452,329
Avg. Volume596,353
Market Cap254.713M
Beta (5Y Monthly)2.05
PE Ratio (TTM)N/A
EPS (TTM)-0.9400
Earnings DateAug 01, 2024 - Aug 05, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.57
  • GlobeNewswire

    Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting

    REDWOOD CITY, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it has successfully synthesized an oligonucleotide via an enzymatic route to support RNA-based therapeutics manufacturing. Data highlighting this historic manufacturing milestone are being presented today in a Spotlight Presentation at the TIDES USA annual meeting taking place in Boston, MA, and virtually May 14 – 17, 2024. “The data presented today by Codexi

  • Simply Wall St.

    Codexis First Quarter 2024 Earnings: Beats Expectations

    Codexis ( NASDAQ:CDXS ) First Quarter 2024 Results Key Financial Results Revenue: US$17.1m (up 32% from 1Q 2023). Net...

  • Insider Monkey

    Codexis, Inc. (NASDAQ:CDXS) Q1 2024 Earnings Call Transcript

    Codexis, Inc. (NASDAQ:CDXS) Q1 2024 Earnings Call Transcript May 2, 2024 Codexis, Inc. beats earnings expectations. Reported EPS is $-0.1647, expectations were $-0.17. Codexis, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Codexis’ First Quarter 2024 […]